Truist Securities Maintains Hold on Gilead Sciences, Raises Price Target to $83
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has maintained a Hold rating on Gilead Sciences (NASDAQ:GILD) and raised the price target from $82 to $83.
August 15, 2024 | 1:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Truist Securities has maintained a Hold rating on Gilead Sciences and raised the price target from $82 to $83.
The raised price target from $82 to $83 indicates a slight positive outlook from Truist Securities, which could lead to a minor positive impact on Gilead Sciences' stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100